We are monitoring the impact of COVID-19 & Recession alarm on Asia Pacific Aptamers Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Aptamers Market Research Report - Segmented By Type, Application, End User, & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1074
Pages: 145

Asia Pacific Aptamers Market Size (2022 to 2027)

The size of the Asia Pacific Aptamers Market has been forecasted at USD 40.94 million in 2022 and will reach USD 112.93 million by the end of 2027, scoring a CAGR of 22.5% between 2022 to 2027.

The growth of the aptamers market in the APAC region is expected to be driven by the aptamer's benefits over antibodies, such as cheap cost and high efficiency, and the range of applications available. Also, market growth is projected to be boosted by continuous technological advancements and their fast implementation throughout the forecast period. Major companies have been making a significant impact in the market in the past few years. Also, introducing a chemical modification technique to improve aptamers' nuclease resistance and therapeutic characteristics boosts the market growth. In addition, the growing amount of research and development (R & R&D) efforts done for developing diagnostic equipment, medicines, and their carriers can also be attributed to the market of aptamers.

The increase of R&D investments is likely to have a favorable influence on market growth. Aptagen, a major participant in the industry, has been developing aptamers for more than 25 years. The company has been developing aptamers for proteins, small molecules, tissues, and cells that are particularly binding and high affinity. In addition, the firm manufactures cutting-edge and innovative components for medicines, bio-industrial, and diagnostic applications. During the forecast period, these trends and developments are likely to influence the market.

On the other hand, the proliferation of life-threatening diseases such as cancer, cardiovascular diseases, AIDS, and neurodegenerative disorders majorly influences the demand for effective assays based on Aptamer therapy. Apart from that, these small molecules offer various advantages in contrast to known antibodies that have led to increased demand for these molecules across a wide variety of medicinal applications. For example, they're chemically produced, so there's no batch-to-batch variance, and development takes less time.

Furthermore, private companies collaborate with academic institutions and research labs to offer next-generation products and enhance their market presence. Aptamers are expected to be used in a wide range of medical therapies and the food and beverage (F&B) sector as a result of this.

However, a lack of skilled professionals may hamper the market growth during the given period. Furthermore, the manufacturers have chosen to avoid using these molecules due to a lack of understanding of aptamers and technical expertise.

This research report segmented and sub-segmented the Asia Pacific Aptamers Market into the following categories:

By Type: 

  • Peptide aptamers
  • Nucleic Acid aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers

By Application: 

  • Therapeutics Development
  • Diagnostics
  • Research and Development

By End User: 

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the APAC is one of the fastest-growing regions in the global aptamers market over the years. It is projected to account for a remarkable share in the global market during the forecast period owing to access to optimum treatment facilities, increasing healthcare spending, and better adoption of technologies. Further, increasing demand for Aptamers, favorable government policies, and the increasing trend of R&D in pharmaceutical and biotechnological industries are fuelling the market growth.

The Chinese aptamers market dominated the APAC aptamers market in 2020 and is estimated to account for the most significant share during the forecast period. The market is more likely to continue its growth throughout the forecast period. China witnessed technological advancements in the healthcare sector owing to the increasing investment and funding by the government.

On the other hand, the Indian Aptamers market is anticipated to record a promising share and contribute to the APAC regional market during the forecast period. Supportive government policies, improving healthcare infrastructure, and ongoing research & development activities have led to adopting Aptamers, leading to market growth.

KEY MARKET PLAYERS:

Companies playing a notable role in the APAC aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia-Pacific Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Peptide Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Nucleic Acid Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Therapeutics Development Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Diagnostics Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific Research and Development Market, By Region, From 2022 - 2027 (USD Million)
  8. Asia-Pacific Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  9. Asia-Pacific Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific Bio-Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific Academic and Rsearch centers Market, By Region, From 2022 - 2027 (USD Million)
  12. Japan Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  13. Japan Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  14. Japan Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  15. China Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  16. China Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  17. China Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  18. India Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  19. India Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  20. India Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  21. Australia Aptamers Market, By Type, From 2022 - 2027 (USD Million)
  22. Australia Aptamers Market, By Application, From 2022 - 2027 (USD Million)
  23. Australia Aptamers Market, By End users, From 2022 - 2027 (USD Million)
  24. Asia-Pacific Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  25. Asia-Pacific DNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  26. Asia-Pacific RNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  27. Asia-Pacific XNA Based Aptamers Market, By Region, From 2022 - 2027 (USD Million)
  28. Japan Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  29. China Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)
  30. India Aptamers Market, By Nucleic Acid Aptamers, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample